$19.56
1.26% today
Nasdaq, Apr 04, 08:43 pm CET
ISIN
US98419J2069
Symbol
XOMA
Sector
Industry

XOMA Corporation Stock price

$19.81
-1.68 7.82% 1M
-6.59 24.96% 6M
-6.47 24.62% YTD
-6.02 23.31% 1Y
-7.85 28.38% 3Y
+1.30 7.02% 5Y
-50.99 72.02% 10Y
Nasdaq, Closing price Thu, Apr 03 2025
+0.03 0.15%
ISIN
US98419J2069
Symbol
XOMA
Sector
Industry

Key metrics

Market capitalization $237.30m
Enterprise Value $250.04m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 8.78
P/S ratio (TTM) P/S ratio 8.33
P/B ratio (TTM) P/B ratio 2.89
Revenue growth (TTM) Revenue growth 498.72%
Revenue (TTM) Revenue $28.49m
EBIT (operating result TTM) EBIT $-39.98m
Free Cash Flow (TTM) Free Cash Flow $-14.51m
Cash position $106.51m
EPS (TTM) EPS $-2.06
P/E forward negative
P/S forward 7.44
EV/Sales forward 7.84
Short interest 1.94%
Show more

Is XOMA Corporation a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,794 stocks worldwide.

XOMA Corporation Stock Analysis

Unlock Scores for Free

Analyst Opinions

3 Analysts have issued a XOMA Corporation forecast:

2x Buy
67%
1x Hold
33%

Analyst Opinions

3 Analysts have issued a XOMA Corporation forecast:

Buy
67%
Hold
33%

Financial data from XOMA Corporation

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
28 28
499% 499%
100%
- Direct Costs 0.22 0.22
78% 78%
1%
28 28
652% 652%
99%
- Selling and Administrative Expenses 65 65
166% 166%
229%
- Research and Development Expense 2.88 2.88
1,957% 1,957%
10%
-40 -40
90% 90%
-140%
- Depreciation and Amortization 0.22 0.22
78% 78%
1%
EBIT (Operating Income) EBIT -40 -40
83% 83%
-140%
Net Profit -14 -14
66% 66%
-49%

In millions USD.

Don't miss a Thing! We will send you all news about XOMA Corporation directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

XOMA Corporation Stock News

Neutral
GlobeNewsWire
2 days ago
EMERYVILLE, Calif., April 02, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (“XOMA”; NASDAQ: XOMA), the biotech royalty aggregator, announced today Chief Investment Officer, Brad Sitko, will be a featured presenter at the Jones Healthcare and Technology Innovation Conference being held April 8-9, 2025.
Neutral
GlobeNewsWire
15 days ago
EMERYVILLE, Calif., March 20, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (Nasdaq: XOMA) today announced its Board of Directors has authorized the following cash dividends to holders of XOMA Royalty's Series A and Series B Cumulative Preferred Stock:
Neutral
GlobeNewsWire
18 days ago
Doubled the royalty and milestone portfolio to over 120 royalty assets with significant milestone potential through five transactions in 2024
More XOMA Corporation News

Company Profile

XOMA Corp. engages in the discovery and development of therapeutics derived from platform of antibody technologies. Its products includes X358, X213, X129, and gevokizumab. The company was founded by Patrick J. Scannon in 1981 and is headquartered in Emeryville, CA.

Head office United States
CEO Owen Hughes
Employees 13
Founded 1981
Website www.xoma.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today